Pediatric Brain Tumor Market Overview
Pediatric brain tumor can be defined as an unnatural growth of a normal cell inside the brain of a children. These tumors are of two types cancerous (malignant) and noncancerous (benign). The type is quite common in children. Governments are putting in great effort to counter this type of disease, which is giving substantial traction to the global pediatric brain tumor market. The market can achieve a growth by 4.1% CAGR during the forecast period to surpass USD 1659.4 million worth mark during the forecast period.
Changing lifestyle factors have triggered a growth in the global prevalence of pediatric brain tumors over the last few years. This is likely to be the main driver for the global pediatric brain tumor market over the forecast period, as the growing prevalence of the disease has raised awareness among parent demographics as well as mobilizing a steady stream of funding from government healthcare agencies to study and tackle the disease. The emotional factor behind pediatric brain cancer is also likely to play a key role in the growth of the global pediatric brain tumor market over the forecast period, as promotional campaigns for pediatric cancer often get more attention from governments and the general populace alike than campaigns focusing on adult cancer. The emotional factor behind pediatric brain cancer is also likely to play a key role in the growth of the global Pediatric Brain Tumor Market over the forecast period, as promotional campaigns for pediatric cancer often get more attention from governments and the general populace alike than campaigns focusing on adult cancer.
The growing healthcare infrastructure in the U.S., Germany, the UK, France, and other leading nations around the world, and the rising funding for clinical trials is likely to be a major driver for the global pediatric brain tumor market over the forecast period. Research efforts aimed at discovering definitive cures for pediatric cancer are likely to play a key role in the growth of the global pediatric brain tumor market over the forecast period, as the causality and progression mechanism of pediatric brain cancer is not understood in its entirety.
Pediatric Brain Tumor Market Segmentation
- A better understanding of the global pediatric brain tumor market can be segmented on the basis of types, diagnosis, and treatment.
- By type, the global pediatric brain tumor market can be segmented into mixed neuronal-glial tumors, gliomas, choroid plexus papilloma/carcinoma, embryonal tumors, meningeal tumors, tumors arising from non-neuroepithelial tissue, and others. The gliomas segment includes malignant gliomas, astrocytoma, and others. Mixed neuronal-glial tumors are segmented into pleomorphic xanthoastrocytoma, subependymal giant cell tumor, ganglioglioma, and others. Embryonal tumors segment encompasses primitive neuroectodermal tumor (PNET), atypical teratoid/rhabdoid tumor, and others. Tumors arising from non-neuroepithelial tissue includes pineal region tumors, craniopharyngioma, and others.
- By treatment, the pediatric brain tumor market has been studied on the basis of therapies, surgery, drug treatment, and others. Surgery segment includes resection (removal), shunt placement/revision, surgical biopsy, and others. Therapies segment has been studied with focus on chemotherapy, radiation therapy, targeted therapy, and others. Chemotherapy segment covers carboplatin, cisplatin, carmustine (BCNU), vincristine, etoposide, cyclophosphamide, methotrexate, lomustine (CCNU), thiotepa, temozolomide, and others. Drug treatment segment includes hormones, corticosteroids, anti-seizure drugs (anti-epileptics), and others.
- Based on the diagnosis, the global pediatric brain tumor market can be segmented into physical exam, Imaging tests, lumbar puncture (spinal tap), brain or spinal cord tumor biopsy, blood & urine tests, and others. Imaging tests includes Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI) scan, Angiogram, Positron Emission Tomography (PET) scan, and others. Magnetic Resonance Imaging (MRI) scan comprises Magnetic Resonance Spectroscopy (MRS), Magnetic Resonance Angiography (MRA), Functional MRI (fMRI), Magnetic Resonance Perfusion, and others. Brain or spinal cord tumor biopsy can be studied better on the basis of craniotomy, stereotactic needle biopsy, and other.
- By end user, the pediatric brain tumor market consists hospitals & clinics, medical research centers, academic institutes, and others.
Pediatric Brain Tumor Market Regional Analysis
North America has the better market coverage and it can grow in the coming years with strong contributions made by the US and Canada. This is due to high level of awareness better market percolation of various industries, hike in healthcare expenditure, and various other factors. Europe is also in the line to earn revenues. The regional healthcare sector has similar market benefits like that of North America. In the APAC region, the market can depend on revamping healthcare sector, which can fetch in better revenues for the market.
By considering the pediatric brain tumor market on a region-specific level, MRFR included regions like North America, Europe, Asia Pacific (APAC), and the Rest-of-the-World (RoW). These segments are expected to thrive on various demographic features that can be studied to increase the profit margin in the coming years.
Pediatric Brain Tumor Market Players
- AbbVie Inc. (US)
- (US)
- Agios, Inc. (US)
- Akorn, Inc. (US)
- Bayer AG (US)
- Baxter (US)
- Novartis AG (Switzerland)
- Epizyme, Inc. (US)
- Mylan N.V. (US)
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/pediatric-brain-tumor-market-3690
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
Market HighlightsThe global pediatric brain tumor market has been evaluated as a steady growing market and it is expected to continue growing soon.
Increasing cases of pediatric brain tumors are leading the market growth.
Various research initiatives taken by government, NGOs and healthcare providers are major driving forces of this market.The market for pediatric brain tumor was around USD 1252.5 million in 2016 and is expected to reach USD 1659.4 million which is projected to grow at a CAGR of 4.1% by 2023.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/3690Major Players in pediatric brain tumor market:There are plenty of large and small market players which operate in this market: Abbott.
(US), AbbVie Inc. (US), Akorn, Inc. (US), Agios, Inc. (US), Baxter (US) , Bayer AG (US), Epizyme, Inc. (US), Novartis AG (Switzerland), Mylan N.V. (US), and othersMajor players are funding large amount of money on research and also adopting collaboration strategy to capture the major market share.
Middle East and Africa Pediatric brain tumor market is expected to limited growth it is mostly because of lack of knowledge of disorder and treatment, limited access to required healthcare facilities etc.Segmentation:Global pediatric brain tumor market has been segmented on the basis of types which comprises of gliomas, mixed neuronal-glial tumors, embryonal tumors, choroid plexus papilloma/carcinoma, tumors arising from non-neuroepithelial tissue, meningeal tumors, and others.
Tumors arising from non-neuroepithelial tissue are further sub-segmented into craniopharyngioma, pineal region tumors, and others.On the basis of diagnosis, it is segmented into physical exam, Imaging tests, brain or spinal cord tumor biopsy, lumbar puncture (spinal tap), blood and urine tests, and others.
Pediatric Brain Tumor Market Information, By Types (Gliomas, Mixed Neuronal-Glial Tumors, Embryonal Tumors, and others), By Diagnosis (Imaging Tests, Brain Or Spinal Cord Tumor Biopsy, and others), By Treatment, By End User- Global Forecast Till 2027The global pediatric brain tumor market is expected to reach a valuation of USD 1,659.4 million by 2023, according to the latest research report from Market Research Future (MRFR).
The global pediatric brain tumor market is mainly driven by the growing awareness about the disease and the increasing investment being made by government agencies in finding effective cures for the disease and the growing prevalence of pediatric brain cancer around the world.Changing lifestyle factors have triggered a growth in the global prevalence of pediatric brain tumors over the last few years.
This is likely to be the main driver for the global pediatric brain tumor market over the forecast period, as the growing prevalence of the disease has raised awareness among parent demographics as well as mobilizing a steady stream of funding from government healthcare agencies to study and tackle the disease.
The emotional factor behind pediatric brain cancer is also likely to play a key role in the growth of the global pediatric brain tumor market over the forecast period, as promotional campaigns for pediatric cancer often get more attention from governments and the general populace alike than campaigns focusing on adult cancer.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3690The growing healthcare infrastructure in the U.S., Germany, the UK, France, and other leading nations around the world, and the rising funding for clinical trials is likely to be a major driver for the global pediatric brain tumor market over the forecast period.
Research efforts aimed at discovering definitive cures for pediatric cancer are likely to play a key role in the growth of the global pediatric brain tumor market over the forecast period, as the causality and progression mechanism of pediatric brain cancer is not understood in its entirety.Industrial Updates:In April 2019, researchers at the Brain Tumor Center at Cincinnati Children’s Hospital Medical Center found a key molecular driver of glioblastoma, a major type of pediatric brain tumor.
The researchers discovered that the transformation of primitive oligodendrocyte progenitors into a stem cell-like state is a key step in the growth of glioblastoma.
An otolaryngist provides specialized care for a wide array of ENT issues, utilizing both surgical and medical skills to properly diagnose and treat individuals suffering with ENT problems.
During this time, students will learn everything from the basics of human anatomy to the latest techniques of ENT surgery.
The ENT specialist is also responsible for treating and diagnosing cases involving the eyes, ears, chest, spine, and even the skin surrounding the nose, ears, and throat.
ENT specialists are licensed and certified by the American Board of Plastic Surgery, and the Certification Board of Facial Plastic and Reconstructive Surgery.
There are several subspecialties within the field of ENT, including pediatric, gynecological, and neurological surgery.
Children, in particular, face many unique concerns that can be remedied with the help of ENT medical care.
